Advancing theory on the multilevel role of leadership in the implementation of evidence-based health care practices.


Journal

Health care management review
ISSN: 1550-5030
Titre abrégé: Health Care Manage Rev
Pays: United States
ID NLM: 7611530

Informations de publication

Date de publication:
Historique:
pubmed: 27 6 2018
medline: 16 6 2021
entrez: 27 6 2018
Statut: ppublish

Résumé

Top managers' transformational leadership is associated with significant influence on subordinates. Yet little is known about the extent to which top managers' transformational leadership influences middle managers' implementation leadership and, ultimately, frontline staff delivery of evidence-based health care practices. To test a multilevel leadership model examining the extent to which top managers' transformational leadership, as mediated by implementation leadership of middle managers (i.e., those who supervise direct clinical services), affects staff attitudes toward evidence-based practices (EBPs) and their implementation. We used data collected in 2013 from 427 employees in 112 addiction health services programs in Los Angeles County, California. We relied on hierarchical linear models with robust standard errors to analyze multilevel data, individuals nested in programs. We conducted two path models to estimate multilevel relationships with two EBPs: contingency management and medication-assisted treatment. Findings partially supported our theory-driven multilevel leadership model. Specifically, results demonstrated that middle managers' implementation leadership mediated the relationship between top managers' transformational leadership and attitudes toward EBPs. At the same time, they showed the mediated relationship for delivery of contingency management treatment was only marginally significant (standardized indirect effect = .006, bootstrap p = .091). We did not find a mediation effect for medication-assisted treatment. Findings advance leadership theory in health care, highlighting the importance of middle managers' implementation leadership in transmitting the influence of top managers' transformational leadership on staff attitudes toward EBPs. The full path model shows the extent to which transformational leadership may influence staff implementation of innovative practices as mediated through staff attitudes toward EBPs and middle managers' implementation leadership. Our findings have implications for developing a multilevel leadership approach to implementation in health care. Leadership development should build on different competencies based on managers' level but align managers' priorities on the same implementation goals.

Sections du résumé

BACKGROUND
Top managers' transformational leadership is associated with significant influence on subordinates. Yet little is known about the extent to which top managers' transformational leadership influences middle managers' implementation leadership and, ultimately, frontline staff delivery of evidence-based health care practices.
PURPOSE
To test a multilevel leadership model examining the extent to which top managers' transformational leadership, as mediated by implementation leadership of middle managers (i.e., those who supervise direct clinical services), affects staff attitudes toward evidence-based practices (EBPs) and their implementation.
METHODOLOGY/APPROACH
We used data collected in 2013 from 427 employees in 112 addiction health services programs in Los Angeles County, California. We relied on hierarchical linear models with robust standard errors to analyze multilevel data, individuals nested in programs. We conducted two path models to estimate multilevel relationships with two EBPs: contingency management and medication-assisted treatment.
RESULTS
Findings partially supported our theory-driven multilevel leadership model. Specifically, results demonstrated that middle managers' implementation leadership mediated the relationship between top managers' transformational leadership and attitudes toward EBPs. At the same time, they showed the mediated relationship for delivery of contingency management treatment was only marginally significant (standardized indirect effect = .006, bootstrap p = .091). We did not find a mediation effect for medication-assisted treatment.
DISCUSSION
Findings advance leadership theory in health care, highlighting the importance of middle managers' implementation leadership in transmitting the influence of top managers' transformational leadership on staff attitudes toward EBPs. The full path model shows the extent to which transformational leadership may influence staff implementation of innovative practices as mediated through staff attitudes toward EBPs and middle managers' implementation leadership.
PRACTICE IMPLICATIONS
Our findings have implications for developing a multilevel leadership approach to implementation in health care. Leadership development should build on different competencies based on managers' level but align managers' priorities on the same implementation goals.

Identifiants

pubmed: 29944489
doi: 10.1097/HMR.0000000000000213
pmc: PMC6309767
mid: NIHMS966160
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-161

Subventions

Organisme : NIDA NIH HHS
ID : R21 DA035634
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA038608
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA038466
Pays : United States
Organisme : NIDA NIH HHS
ID : R33 DA035634
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH072961
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH092950
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH080916
Pays : United States

Références

Health Care Manage Rev. 2017 Jan/Mar;42(1):14-27
pubmed: 26488239
Adm Policy Ment Health. 2016 Jan;43(1):23-35
pubmed: 25450596
Implement Sci. 2016 May 14;11:69
pubmed: 27180231
Addiction. 2006 Nov;101(11):1546-60
pubmed: 17034434
Addiction. 2006 Feb;101(2):192-203
pubmed: 16445548
Implement Sci. 2015 Jan 16;10:11
pubmed: 25592163
Adm Policy Ment Health. 2011 Jan;38(1):4-23
pubmed: 21197565
Psychol Assess. 2010 Jun;22(2):356-65
pubmed: 20528063
Subst Use Misuse. 2010 Jul;45(9):1279-302
pubmed: 20509734
Implement Sci. 2017 Nov 14;12(1):133
pubmed: 29137668
J Subst Abuse Treat. 2006 Oct;31(3):221-33
pubmed: 16996385
Eval Program Plann. 2013 Oct;40:74-81
pubmed: 23816502
Psychol Addict Behav. 2011 Jun;25(2):225-37
pubmed: 21668085
Adm Policy Ment Health. 2014 Nov;41(6):737-49
pubmed: 24046236
J Appl Psychol. 2003 Apr;88(2):207-18
pubmed: 12731705
Child Abuse Negl. 2016 Mar;53:17-26
pubmed: 26563643
J Appl Psychol. 2004 Apr;89(2):322-33
pubmed: 15065978
J Subst Abuse Treat. 2007 Mar;32(2):121-31
pubmed: 17306721
Health Care Manage Rev. 2010 Jul-Sep;35(3):235-45
pubmed: 20551771
Annu Rev Public Health. 2014;35:255-74
pubmed: 24641560
Harv Bus Rev. 2005 Jun;83(6):112-20, 150
pubmed: 15938442
N Engl J Med. 2014 May 29;370(22):2063-6
pubmed: 24758595
Health Care Manage Rev. 2015 Apr-Jun;40(2):159-68
pubmed: 24566252
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Eval Program Plann. 2011 Nov;34(4):375-81
pubmed: 21371752
Psychiatr Clin North Am. 2003 Dec;26(4):991-1010
pubmed: 14711132
J Subst Abuse Treat. 2016 Sep;68:31-5
pubmed: 27431044
Implement Sci. 2012 Apr 03;7:28
pubmed: 22472001

Auteurs

Erick G Guerrero (EG)

Erick G. Guerrero, PhD, is Associated Professor, Marshall School of Business and Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles; and Executive Director of the Integrative Leadership to End Addiction Disparities (i-LEAD) Institute. E-mail: erickgue@usc.edu. Jemima Frimpong, PhD, is Assistant Professor, Business School at John Hopkins University, Baltimore, Maryland. Yinfei Kong, PhD, is Assistant Professor, Mihaylo College of Business and Economics, California State University, Fullerton. Karissa Fenwick, MSW, is Student, Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles. Gregory A. Aarons, PhD, is Professor, Department of Psychiatry, University of California, San Diego.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH